Navigation Links
Mechanism for esophageal cancer uncovered
Date:4/11/2011

A gene thought to be associated with cancer development can be a tumor suppressor gene in mice, researchers have discovered. Understanding which genes are involved in spreading cancer could lead to future therapies.

"For cancer to spread, some genes are activated, while others that would prevent cancer growth are prevented from doing their jobs. The cancer research community has thought that the gene p120, falls into the latter category," said Douglas Stairs, Ph.D., assistant professor of pathology, who completed this research at University of Pennsylvania and is now at Penn State College of Medicine. "In this research, the loss of the p120 gene led to the development of cancer."

Stairs worked with colleagues at Vanderbilt University to create a mouse model to study the gene. Called a knockout mouse, these specially bred mice do not have the p120 gene in their mouths and esophagi. Researchers then studied the mice to see if tumors formed in those areas. In 70 percent of p120 knockout mice, tumors formed.

Researchers observed that mice that had cancer had hyperactivated immune systems. Absence of p120 led to the production of immune cells that are pro-tumor generating and pro-cancer forming.

"For cancer, the immune system can both help and hurt the body," Stairs said. "Some immune cells help the body get rid of the cancer cells, while other immune cells help tumors to form. When p120 was absent, tumor promotion through the immune system was activated. The mice produced the bad types of immune cells." The researchers published their results in the journal Cancer Cell.

Researchers learned through further investigation that these "bad" immune cells traveled to the esophagus and improperly activated fibroblasts. Fibroblasts are cells that create the support structure for tissues. They are most noticeably activated when tissue damage occurs and scarring is a result of the fibroblast cells activating. Fibroblasts are also activated in cancer patients.

By improperly activating the fibroblasts, the immune cells were able to stay active longer than normal.

"Each feeds off the other," Stairs said. "It creates an environment that is very permissive for cancer development." Stairs is now working to identify which proteins are used to communicate between tumor cells and other cells in the tumor microenvironment -- the immune cells and fibroblasts. He aims to discover how cells that lose p120 interact with the immune system, which, in turn, interacts with the fibroblasts. "Once we know that," he said, "we can then potentially develop a strategy to break those relationships -- a therapy."

The creation of the p120 knockout mouse will also help other researchers, providing a model for esophageal cancer that did not exist before.


'/>"/>

Contact: Matt Solovey
msolovey@hmc.psu.edu
717-531-8606
Penn State
Source:Eurekalert

Related medicine news :

1. Mechanism for invasion of tumorous cells discovered by Hebrew University researchers
2. Mount Sinai finds promising clue to mechanism behind gene mutation that causes Parkinsons disease
3. Scientists find key mechanism of childhood respiratory disease
4. Novel mechanism for control of gene expression revealed
5. Researchers find new mechanism behind the formation and maintenance of long-term memories
6. New study finds molecular mechanisms that control Rb2/p130 gene expression in lung cancer
7. Unexpected new mechanism behind rheumatoid arthritis
8. Princeton scientists discover mechanism involved in breast cancers spread to bone
9. UCLA researchers uncover new cell biological mechanism that regulates protein stability in cells
10. UCI researchers find novel memory-enhancing mechanism in brain
11. A new mechanism for reversible proteasome inhibition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... OH (PRWEB) , ... December 02, 2016 , ... ... of veterinarian diagnostic imaging systems and the first company to offer ... With a Heart at their tradeshow booth # 941 for the American Association ...
(Date:12/2/2016)... ... December 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh in ... fits into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started ... how the details line up exactly with Bible Prophecy – a protected way for ...
(Date:12/2/2016)... ... December 02, 2016 , ... On ... individuals and families from eight different sites throughout Miami-Dade and Broward counties. This ... volunteers worked very hard on Thanksgiving morning by putting together individual meals via ...
(Date:12/2/2016)... ... 2016 , ... ‘Tis the season for giving! Today, 20 creative teams across ... Partnership and the Drug Enforcement Administration as part of the National Red Ribbon Week ... schools who decorated their campuses with this year’s Red Ribbon Week theme: “YOLO. Be ...
(Date:11/30/2016)... ... November 30, 2016 , ... "I hate when the mixture of saliva ... teeth," said an inventor from Bridgewater, N.J. "I thought that there had to be ... , He developed the patent-pending DEFLECTOR to prevent saliva and toothpaste from running down ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , December 2, 2016 ... Vitro Diagnostics/IVD Market by Product (Instruments, Reagents, Software), ... (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - Forecast ... is valued at USD 60.22 Billion in 2016. ... CAGR of 5.5% during the forecast period (2016-2021) ...
(Date:12/2/2016)...  PipelineRx, a leading medication management technology company ... of its SaaS-based telepharmacy platform, PowerGridRx™ , ... Midyear Clinical Meeting and Exhibition, December 5-7 in ... 300 hospital clients nationally, the Company is a ... dramatically improve pharmacy operations, enhance patient safety, and ...
(Date:12/2/2016)... -- On Thursday, December 1st 2016, the ... development and innovation in the biopharmaceutical industry at its ... the presence of Sergey Tsyb, Vice Minister of Industry ... , Natalia Sanina, First Vice Chairman of the State ... Roszdravnadzor, National Service of Control in Healthcare, Sergey Muravev, ...
Breaking Medicine Technology: